GeneDx Holdings Corp. Financial Flexibility Index
GeneDx Holdings Corp. financial flexibility index. GeneDx Holdings Corp. (WGS) has a Financial Flexibility Index of -0.08x as of June 2026. Free cash flow of $-18.87 Million (operating CF $-28.98 Million minus capex $10.11 Million) represents 0% of total liabilities ($237.26 Million). Explore how much does GeneDx Holdings Corp. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GeneDx Holdings Corp. (2020–2025)
Financial flexibility index of GeneDx Holdings Corp. from 2020 to 2025. Historical Financial Flexibility Index trend for GeneDx Holdings Corp. across 6 annual periods. Check GeneDx Holdings Corp. (WGS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
GeneDx Holdings Corp. Financial Flexibility Index by Year (2020–2025)
GeneDx Holdings Corp. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for GeneDx Holdings Corp.. For the full cash flow conversion analysis, see WGS cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $52.30 Million | $33.28 Million | $262.01 Million | ▲ +251.1% |
| 2024 | -0.13x | $-23.00 Million | $-28.50 Million | $174.13 Million | ▲ +85.6% |
| 2023 | -0.91x | $-174.44 Million | $-180.15 Million | $190.74 Million | ▲ +12.5% |
| 2022 | -1.05x | $-304.83 Million | $-319.15 Million | $291.56 Million | ▼ -2.3% |
| 2021 | -1.02x | $-169.65 Million | $-190.43 Million | $165.99 Million | ▼ -313.2% |
| 2020 | -0.25x | $-61.15 Million | $-93.13 Million | $247.25 Million | — |